StockData
Alamar Biosciences, Inc. logo

Alamar Biosciences, Inc. (ALMR) stock

ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.51−0.13 (-0.42%)

Close on Nov 18, 2026Market cap $2.12BP/E –Yield –

Alamar Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$15.14M–
Q2 FY2026Jun 30, 2026-$13.53M–
Q1 FY2026Mar 31, 2026-$12.35M–
Q3 FY2025Sep 30, 2025-$7.89M–
Q2 FY2025Jun 30, 2025-$7.92M–
Q1 FY2025Mar 31, 2025-$8.55M–

More Alamar Biosciences figures

See a number that looks wrong?